← Open Payments lookup

MARK LIGORSKI: Open Payments

NPI 1659465003 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,009 in 47 payments from 13 companies in 2025. Trend: 2023 $862 · 2024 $2,935 · 2025 $1,009

Food & beverage: $1,009
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.9$165
Takeda Pharmaceuticals U.S.A., Inc.5$141
ABBVIE INC.6$138
Neurocrine BioSciences, Inc.5$120
Corium, LLC5$91
Teva Pharmaceuticals USA, Inc.4$85
Tris Pharma Inc4$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$68
Axsome Therapeutics, Inc.2$46
Janssen Pharmaceuticals, Inc1$29

Products named: FANAPT, TRINTELLIX, VRAYLAR, INGREZZA, Azstarys, AUSTEDO XR, CAPLYTA, Dyanavel XR.

Industry payments across CT — which companies pay providers there.